Alanazi, A.S.; Alanazi, A.A.; Alanizi, A.; Babalghaith, R.; Alotaibi, R.; Alnuhait, M.; Bakhribah, H.
Trastuzumab Deruxtecan-Associated Interstitial Lung Disease: Real-World Insights from a Tertiary Care Center. Curr. Oncol. 2025, 32, 575.
https://doi.org/10.3390/curroncol32100575
AMA Style
Alanazi AS, Alanazi AA, Alanizi A, Babalghaith R, Alotaibi R, Alnuhait M, Bakhribah H.
Trastuzumab Deruxtecan-Associated Interstitial Lung Disease: Real-World Insights from a Tertiary Care Center. Current Oncology. 2025; 32(10):575.
https://doi.org/10.3390/curroncol32100575
Chicago/Turabian Style
Alanazi, Ahmed S., Ahmed A. Alanazi, Abdalrhman Alanizi, Ranad Babalghaith, Reema Alotaibi, Mohammed Alnuhait, and Hatoon Bakhribah.
2025. "Trastuzumab Deruxtecan-Associated Interstitial Lung Disease: Real-World Insights from a Tertiary Care Center" Current Oncology 32, no. 10: 575.
https://doi.org/10.3390/curroncol32100575
APA Style
Alanazi, A. S., Alanazi, A. A., Alanizi, A., Babalghaith, R., Alotaibi, R., Alnuhait, M., & Bakhribah, H.
(2025). Trastuzumab Deruxtecan-Associated Interstitial Lung Disease: Real-World Insights from a Tertiary Care Center. Current Oncology, 32(10), 575.
https://doi.org/10.3390/curroncol32100575
